• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: January 30-February 3, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

January 30-February 3, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Counselor to the Commissioner1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Acting Chief Counsel1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/1/12Alexandria, VAAshley ShawAnimal Health Institute Government Communications CommitteeCenter for Veterinary Medicine Update
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/3/12Rockville, MDTracey Forfa, William Flynn, David White, Steve Vaughn, Roxanne Schweitzer, Barry Hooberman, Susan Dewitt, Ann Norris, Abena ApauJuliane Park, Jordan Bar (McKinsey Group)Risk Based Resource Allocation Tool
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health1/30/12-2/3/12 N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Jim Sigg, Acting Associate Commissioner for Operations1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/1/12Silver Spring, MDCharles Zimliki, Patricia Beaston, Xuefeng Li, Michelle Chenault, Veronica Sansing, Nicole Jones, Arleen Pinkos, Leslie Landree, Anna Ghambaryan, Samantha Jacobs, Courtney  Lias, Nancy Pluhowski, Richard Chapman, Danica Marinac-Dabic, Richard KotzDana Ball and David Panzirer (The Leona M. and Harry B. Helmsley Charitable Trust)Helmsley Trust T1D program
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco1/30/12Gaithersburg, MDN/AN/ARemarks at the Pediatric Advisory Committee Meeting
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco2/2/12Silver Spring, MDN/ASteven DeKosky (University of Virginia); Julie Jolly, Michael Ledford (Lewis-Burke Associates)Translational and Regulatory Sciences
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco2/4/12Boston, MAN/AN/AHarvard Business School Healthcare Conference
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods1/31/12TeleconferenceRebecca Buckner, Caitlin Boon, Sharon NatanblutMike Robach (Cargill); Frank Yiannas (Walmart); Global Food Safety Initiative Executive Board MembersFood Safety Modernization Act
Mary Lou Valdez, Associate Commissioner for International Programs1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs1/30/12-2/3/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research1/31/12Washington, DCDavid Jacobson-Kram, Tood Bourcier, Daniel Fabricant, Antonia Mattia, Abigail JacobsPeter Kim (Merck Research Laboratories); Lewis Kinter (Astra-Zeneca); Joe DeGeorge (Merck); Robert Johnson (Novartis); Lorrene Buckley (Eli Lilly)37th Annual Winter Meeting of the Toxicology Forum
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/2/12Alexandria, VAHeidi Marchand, Anna Fine, Lesley MaloneyDavid Clark (Academy of Managed Care Pharmacy); Brian Crabtree (American Association of Colleges of Pharmacy); Nelson Showalter (American College of Apothecaries); Carmen Catizone (National Association of Boards of Pharmacy) Joint Commission of Pharmacy Practitioners Meeting